Trabulsy P P, Anthony J P, Mathes S J
Plast Reconstr Surg. 1994 Jun;93(7):1418-27. doi: 10.1097/00006534-199406000-00014.
Over the past two decades, significant advances have been made in the treatment of breast cancer and reconstruction following mastectomy. This analysis represents a 13-year review (1979-1991) of 455 postmastectomy reconstructions involving 381 patients (age range 25 to 76 years, mean 51 years). Follow-up was 6 months to 13 years (mean 5 years). Timing of the reconstruction, reconstructive techniques used, incidence of complications, and final results were determined. Reconstructions were divided into three chronologic study groups: group I, 1979-1983; group II, 1984-1987; and group III, 1988-1991. A significant increase in the use of autogenous reconstruction was identified: 13 percent in group I to 37 percent in group III (p < 0.0002). Complication rates were not significantly different among the three groups (p > 0.02). Significant decreases in the use of implants alone and the latissimus dorsi flap with implant were identified, while tissue expansion and TRAM flap use increased significantly (p < 0.002). Also, a significant increase in immediate reconstruction from 6 percent in group I to 28 percent in group III occurred (p < 0.0002). There was no significant difference in complication rates between immediate and delayed reconstruction in any study group. Operative time averaged 2 hours less for nonautogenous techniques; however, autogenous reconstruction required significantly fewer operative revisions. The identified trends toward immediate reconstruction and use of autogenous tissue have been accomplished without an increase in complications. Despite a decrease in overall implant use, the textured silicone saline-filled expander/implant remains the most frequently used device for breast reconstruction, providing a safe and predictable method to accomplish both immediate and delayed postmastectomy reconstruction.
在过去二十年中,乳腺癌治疗及乳房切除术后重建取得了重大进展。本分析对1979年至1991年期间381例患者(年龄范围25至76岁,平均51岁)的455例乳房切除术后重建进行了为期13年的回顾。随访时间为6个月至13年(平均5年)。确定了重建的时间、所采用的重建技术、并发症发生率及最终结果。重建被分为三个按时间顺序排列的研究组:第一组,1979年至1983年;第二组,1984年至1987年;第三组,1988年至1991年。发现自体组织重建的使用率显著增加:第一组为13%,第三组为37%(p<0.0002)。三组之间的并发症发生率无显著差异(p>0.02)。发现单纯使用植入物及背阔肌肌皮瓣联合植入物的使用率显著下降,而组织扩张术及横行腹直肌肌皮瓣(TRAM瓣)的使用显著增加(p<0.002)。此外,即刻重建的比例从第一组的6%显著增加至第三组的28%(p<0.0002)。在任何研究组中,即刻重建与延迟重建的并发症发生率均无显著差异。非自体技术的平均手术时间少2小时;然而,自体组织重建所需的手术翻修次数显著减少。已实现的即刻重建及使用自体组织的趋势并未导致并发症增加。尽管总体植入物使用量有所下降,但带纹理的硅凝胶盐水填充式扩张器/植入物仍是乳房重建中最常用的装置,为完成乳房切除术后即刻及延迟重建提供了一种安全且可预测的方法。